CN104524448B - A kind of Chinese medicine preparation preparation method for treating fatty liver and hyperlipidemia - Google Patents
A kind of Chinese medicine preparation preparation method for treating fatty liver and hyperlipidemia Download PDFInfo
- Publication number
- CN104524448B CN104524448B CN201410794632.XA CN201410794632A CN104524448B CN 104524448 B CN104524448 B CN 104524448B CN 201410794632 A CN201410794632 A CN 201410794632A CN 104524448 B CN104524448 B CN 104524448B
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- ethyl alcohol
- hyperlipidemia
- fatty liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 208000004930 Fatty Liver Diseases 0.000 title claims abstract description 20
- 206010019708 Hepatic steatosis Diseases 0.000 title claims abstract description 20
- 231100000240 steatosis hepatitis Toxicity 0.000 title claims abstract description 20
- 206010062060 Hyperlipidaemia Diseases 0.000 title claims abstract description 19
- 235000019441 ethanol Nutrition 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 12
- 239000006228 supernatant Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000016855 Biancospino Nutrition 0.000 claims abstract description 6
- 244000062995 Cassia occidentalis Species 0.000 claims abstract description 6
- 235000001948 Cassia occidentalis Nutrition 0.000 claims abstract description 6
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 6
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 6
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 6
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 6
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 6
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 6
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 6
- 239000009636 Huang Qi Substances 0.000 claims abstract description 6
- 240000001313 Lycium barbarum Species 0.000 claims abstract description 6
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 6
- 244000153955 Reynoutria sachalinensis Species 0.000 claims abstract description 6
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims abstract description 6
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 6
- 229940079593 drugs Drugs 0.000 claims abstract description 6
- 235000002313 hawthorn Nutrition 0.000 claims abstract description 6
- 235000009444 hawthorn Nutrition 0.000 claims abstract description 6
- 235000009486 hawthorn Nutrition 0.000 claims abstract description 6
- 235000009682 hawthorn Nutrition 0.000 claims abstract description 6
- 235000009685 hawthorn Nutrition 0.000 claims abstract description 6
- 235000009917 hawthorn Nutrition 0.000 claims abstract description 6
- 235000013161 hawthorn Nutrition 0.000 claims abstract description 6
- 235000013165 hawthorn Nutrition 0.000 claims abstract description 6
- 235000013189 hawthorn Nutrition 0.000 claims abstract description 6
- 235000013204 hawthorn Nutrition 0.000 claims abstract description 6
- 235000013214 hawthorn Nutrition 0.000 claims abstract description 6
- 235000013246 hawthorn Nutrition 0.000 claims abstract description 6
- 235000017423 hawthorn Nutrition 0.000 claims abstract description 6
- 235000013976 turmeric Nutrition 0.000 claims abstract description 6
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 5
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 5
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 5
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 5
- 238000011049 filling Methods 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 4
- 238000003306 harvesting Methods 0.000 claims abstract description 4
- 230000001954 sterilising Effects 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 239000003765 sweetening agent Substances 0.000 claims abstract description 4
- 238000007792 addition Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims 1
- 239000000284 extract Substances 0.000 abstract description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 32
- 229940107161 Cholesterol Drugs 0.000 description 16
- 235000012000 cholesterol Nutrition 0.000 description 16
- 210000004369 Blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 150000003626 triacylglycerols Chemical class 0.000 description 7
- 208000004981 Coronary Disease Diseases 0.000 description 4
- 208000002173 Dizziness Diseases 0.000 description 4
- 210000003128 Head Anatomy 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 210000004185 Liver Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 201000008739 coronary artery disease Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000015263 low fat diet Nutrition 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 210000004556 Brain Anatomy 0.000 description 3
- 206010008118 Cerebral infarction Diseases 0.000 description 3
- 210000003414 Extremities Anatomy 0.000 description 3
- 229940100688 Oral Solution Drugs 0.000 description 3
- 201000007201 aphasia Diseases 0.000 description 3
- 230000002490 cerebral Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 210000001015 Abdomen Anatomy 0.000 description 2
- 206010002855 Anxiety Diseases 0.000 description 2
- 208000007379 Muscle Hypotonia Diseases 0.000 description 2
- 206010028372 Muscular weakness Diseases 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000002440 hepatic Effects 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 230000036473 myasthenia Effects 0.000 description 2
- 108010082126 Alanine Transaminase Proteins 0.000 description 1
- 206010003658 Atrial fibrillation Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008909 Chronic hepatitis Diseases 0.000 description 1
- 210000004351 Coronary Vessels Anatomy 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 206010016256 Fatigue Diseases 0.000 description 1
- 102100010966 GPT Human genes 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000006454 Hepatitis Diseases 0.000 description 1
- 208000002672 Hepatitis B Diseases 0.000 description 1
- 206010061255 Ischaemia Diseases 0.000 description 1
- 210000004731 Jugular Veins Anatomy 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 210000004072 Lung Anatomy 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 210000001331 Nose Anatomy 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 210000000952 Spleen Anatomy 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 206010043949 Tongue discolouration Diseases 0.000 description 1
- 206010043972 Tongue paralysis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000038129 antigens Human genes 0.000 description 1
- 108091007172 antigens Proteins 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 201000010238 heart disease Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 230000002107 myocardial Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Abstract
The present invention provides a kind of Chinese medicine preparation preparation method for treating fatty liver and hyperlipidemia, including：(1) curcuma zedoary of certain mass, radix paeoniae rubra, hawthorn, gynostemma pentaphylla, Cassia occidentalis, giant knotweed, turmeric, Radix Astragali, matrimony vine are weighed；(2) water of 68 times of weight of the total weight of the nine traditional Chinese medicines of the above selection is taken to be decocted, it decocts three times, it boils 40 50 minutes every time, it filters and merges decoction liquor, it is concentrated into the inspissated juice of relative density 1.15 1.30 at a temperature of 80 DEG C, then the ethyl alcohol that mass percent concentration is 95% is added at ambient temperature, it is stirring while adding, then place 24 hours or more, extract supernatant；(3), the ethyl alcohol in supernatant is recycled, then gives back in the supernatant for harvest ethyl alcohol and sweetener is added, the pH value for adjusting solution is 5.0 7.0, finally adds suitable quantity of water；Filtering, sterilizing and filling.Chinese medicine preparation prepared by preparation method of the present invention can effectively treat fatty liver and hyperlipidemia, and cheap.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines more particularly to a kind of Chinese medicine preparations for treating fatty liver and hyperlipidemia
Preparation method.
Background technology
Fatty liver is a kind of disease relatively conventional in modern diseases.The disease incidence up to 50% or so, and focus mostly in
30~60 years old males.Mild fatty liver is mostly without clinical symptoms.In, severe fatty liver have the performance of similar chronic hepatitis, can have
Loss of appetite, lassitude and weak, Nausea and vomiting, hepatic region or upper right abdomen secret anguish, if cannot effectively treat, to eventually result in liver hard
Change etc..Hyperlipidemia is a kind of rich people's disease for perplexing modern, it can increase the viscosity of blood, endangers blood circulation system and forms blood
Pipe hardens.Hyperlipidemia can lead to coronary heart disease, hypertension.Eventually lead to diabetes, sudden death of heart disease, apoplexy etc..To being at present
Only, Western medicine there is no prevention fatty liver and hyperlipidemia active drug, though and have some treat patients in terms of Chinese medicine composition,
Using the Chinese medicine composition of current preparation method preparation, its curative effect is not good enough, therefore, needs the existing side for preparing Chinese medicine composition
Method is improved, to improve curative effect.
Invention content
It is an object of the invention to solve the problems of the above-mentioned prior art, provide a kind of for treating fatty liver and height
The Chinese medicine preparation preparation method of pionemia, the Chinese medicine preparation treatment patient outcome prepared using the preparation method are apparent.
A kind of Chinese medicine preparation preparation method for treating fatty liver and hyperlipidemia includes the following steps：
(1) curcuma zedoary of certain mass, radix paeoniae rubra, hawthorn, gynostemma pentaphylla, Cassia occidentalis, giant knotweed, turmeric, Radix Astragali, matrimony vine are weighed；
(2) it takes the water of 6-8 times of weight of the total weight of the nine traditional Chinese medicines of the above selection to be decocted, decocts three times, every time
It boils 40-50 minutes, filters and merge decoction liquor, the inspissated juice of relative density 1.15-1.30 is concentrated at a temperature of 80 DEG C,
The ethyl alcohol that mass percent concentration is 95% is added at ambient temperature again, it is stirring while adding, then place 24 hours or more, it carries
Take supernatant；
(3), the ethyl alcohol in supernatant is recycled, then gives back in the supernatant for harvest ethyl alcohol and sweetener is added, adjusted molten
The pH value of liquid is 5.0-7.0, finally adds suitable quantity of water；
(4), preparation can be completed in filtering, sterilizing and filling.
Further, the Chinese medicine preparation preparation method as described above for treating fatty liver and hyperlipidemia, the matter
The addition for the ethyl alcohol that amount percent concentration is 95% is 1.2-2 times of the gross mass of inspissated juice.
Further, the Chinese medicine preparation preparation method for treating fatty liver and hyperlipidemia as described above, in step 1
The mass parts of each traditional Chinese medicinal components are:15 parts -75 parts of curcuma zedoary, 12 parts -60 parts of radix paeoniae rubra, 12 parts -60 parts of hawthorn, gynostemma pentaphylla 12
- 60 parts of part, 12 parts -60 parts of Cassia occidentalis, 15 parts -75 parts of giant knotweed, 12 parts -60 parts of turmeric, 15 parts -75 parts of Radix Astragali, matrimony vine 15
- 75 parts of part.
Provided by the present invention for treating the Chinese medicine preparation preparation method of fatty liver and hyperlipidemia, fat can be effectively treated
Fat liver and hyperlipidemia, and it is cheap.
Specific implementation mode
To make the object, technical solutions and advantages of the present invention clearer, the technical solution below in the present invention carries out clear
Chu is fully described by, it is clear that described embodiments are some of the embodiments of the present invention, instead of all the embodiments.It is based on
Embodiment in the present invention, those of ordinary skill in the art are obtained every other without creative efforts
Embodiment shall fall within the protection scope of the present invention.
The treatment fatty liver of the present invention and the Chinese medicine preparation preparation method of hyperlipidemia are as follows：
(1) 15 parts -75 parts of curcuma zedoary of selection, 12 parts -60 parts of radix paeoniae rubra, 12 parts -60 parts of hawthorn, 12 parts -60 parts of gynostemma pentaphylla,
12 parts -60 parts of Cassia occidentalis, 15 parts -75 parts of giant knotweed, 12 parts -60 parts of turmeric, 15 parts -75 parts of Radix Astragali, 15 parts -75 parts of matrimony vine；
(2) it takes the water of 6-8 times of weight of the total weight of the nine traditional Chinese medicines of the above selection to be decocted, decocts three times, every time
It boils 40-50 minutes, filters and merge decoction liquor, be concentrated into the inspissated juice of relative density 1.15-1.30 (80 DEG C), then in room temperature
Under the conditions of the ethyl alcohol that mass percent concentration is 95% is added, the addition of the ethyl alcohol is the 1.2-2 of the total weight of inspissated juice
Times, it is stirring while adding, after addition, place 24 hours or more, extract supernatant；
(3), remaining ethyl alcohol in supernatant is recycled, gives back to and sweetener is added in the supernatant for harvest ethyl alcohol, adjusted molten
The pH value of liquid is 5.0-7.0, and finally plus water stirs evenly standing；
(4), preparation can be completed in filtering, sterilizing and filling.
It is by using Chinese medicine preparation treatment curative effect prepared by preparation method of the present invention below：
Example 1：
Name:So-and-so tall gender：Female's age：61 years old addresses：Xinxiang Ma little Ying
There is aphasia in patient, upper left myasthenia of limbs is admitted to hospital, with dizziness, palpitaition, difference of receiving.Human health screening, blood pressure 170/
100mmhg, sanity, aphasia, left center face tongue paralysis, white and greasy fur, Cervical Vessels are not heard and exception.Under upper left
4 grades of muscular strength, hypomyotonia, left side pathology sign are positive.Head CT shows that multiple cerebral, blood fat show total cholesterol 7.28mol/
L, triglyceride 2.19mol/L, high density cholesterol 1.22mol/L, low density cholesterol 4.70mol/L.Enter section's diagnosis：It is multiple
Property cerebral infarction, hyperlipidemia.It is routinely given to symptomatic treatments such as anti-bolt, improvement brain blood circulations after entering section, while adding and using mouth of the present invention
It takes liquid 20ml/ times, takes orally 3 times a day, blood fat is checked after 20 days and shows that 3.87mol/L, triglyceride 1.5mol/L, high density courage consolidate
Alcohol 1.92mol/L, low density cholesterol 2.28mol/L, is obviously improved when being relatively admitted to hospital, significant in efficacy, advises usually low fat diet, after
Continuous oral maintaining treatment.
Example 2：
Name:Yang's gender：The male age：58 years old addresses：Newly there is burst dizziness in electric cell patient in Xinxiang, left
Side myasthenia of limbs is admitted to hospital, with dizziness, palpitaition, difference of receiving, existing coronary heart disease, atrial fibrillation disease official.Human health screening, blood pressure 150/90mmhg,
Sanity, spirit is poor, and speech is fluent, and tongue nature is slightly dark, white and greasy fur, and Cervical Vessels are not heard and exception.5 grades of muscular strength under upper left,
Hypomyotonia, left side pathology sign are positive.Head MRL shows that multiple cerebral, blood fat show total cholesterol 6.15mol/L, glycerine
Three fat 2.95mol/L, high density cholesterol 0.75mol/L, low density cholesterol 4.36mol/L.Enter section's diagnosis：Cerebral infarction is high
Pionemia.It is routinely given to symptomatic treatments such as anti-bolt, improvement brain blood circulations after entering section, while adding use oral solution of the present invention 20ml/ times,
It takes orally 3 times a day, blood fat is checked after 20 days and shows 3.51mol/L, triglyceride 0.58mol/L, high density cholesterol 2.12mol/
L, low density cholesterol 1.78mol/L, is obviously improved when being relatively admitted to hospital, significant in efficacy, advises usually low fat diet, continues oral maintenance
Treatment.
Example 3：
Name:So-and-so gender of Meng：Female's age：60 years old addresses：Xinxiang West Platform head
There is left limb hemiplegia 2 weeks in patient, and abdominal distension is received poor 10 days and is admitted to hospital, the past body obesity, 10 years high blood pressures
Official, human health screening, weight 80KG, blood pressure 164/102mmhg, sanity, spirit is poor, and aphasia, abdominal distension, appetite is fine,
No nausea is intended to spit, when feel nose heave, tongue nature is slightly dark, and tongue is greasy in vain, and stringy and hesitant pulse, neck is soft, 3 grades of muscular strength under upper right, and pathology sign in right side is negative.
Head MRL shows that multiple cerebral, encephalatrophy, blood fat show total cholesterol 8.12mol/L, triglyceride 5.26mol/L, high density
Cholesterol 0.79mol/L, low density cholesterol 5.53mol/L.Enter section's diagnosis：Cerebral infarction, hyperlipidemia.It is routinely given after entering section
Anti- bolt improves the symptomatic treatments such as brain blood circulation, while adding use oral solution of the present invention 20ml/ times, takes orally 3 times a day, multiple after 20 days
Fat of having a blood test shows 5.03mol/L, triglyceride 2.58mol/L, high density cholesterol 1.52mol/L, low density cholesterol
2.38mol/L is obviously improved when being relatively admitted to hospital, significant in efficacy, advises usually low fat diet, continues oral maintaining treatment.
Example 4：
Name：Slowly so-and-so gender：The male age：55 years old
There is dizzy, weak, right hypochondriac region discomfort in patient before last week, secret anguish gradually aggravates to be admitted to hospital, with loss of appetite, abdomen
It is swollen, belch, hepatic region turgor；Previously there is high blood pressure medical history 10 years；History of coronary heart disease 5 years.Physical examination, 160/95mmhg, mind is clear,
Spiritual poor, chronic face, auscultation of lung no abnormality seen, heart circle expand to left down, 70 beats/min of heart rate.A2>P2, abdominal distention, liver
Palpation of spleen owes satisfaction, and Murphy signs are negative, have no liver distension of jugular vein.Other are checked：Electrocardio illustrates：Deficiency myocardial blood supply surpasses
Sound prompts:Severe fatty liver；Chemically examine blood fat, total cholesterol 7.2mmol/L, triglyceride 4.8mmol/L, low-density lipoprotein
0.86mmol/L.Liver function：Glutamic-oxalacetic transaminease 51mmol/L, glutamic-pyruvic transaminase 78mmol/L, hepatitis B surface antigen (-) property surpass
Sound prompts:Severe fatty liver；Clinical diagnosis：1 fatty liver (severe) 2, hyperlipidemia 3,2 grade 4 of hypertension, coronary heart disease；Main application
Following therapy, reducing blood lipid, decompression, expansion of coronary artery wait symptomatic treatments, while adding and using oral solution of the present invention
20ml/ times, 3 times a day；Symptom is substantially reduced, and blood pressure stabilization is normal, and the aobvious amount of electrocardiogram degree of ischemia mitigates, under the aobvious amount of blood fat
Drop, significantly effectively reach clinical cure standard, the 23rd day check blood fat, total cholesterol 4.8mmol/L, triglyceride 1.5mmol/L,
Low-density albumen 3.21mmol/L, high-density protein 1.98mmol/L.It advises patient's low fat diet, moderate exercise to adhere to taking medicine, consolidates
Gu curative effect.
Finally it should be noted that：The above embodiments are merely illustrative of the technical solutions of the present invention, rather than its limitations；Although
Present invention has been described in detail with reference to the aforementioned embodiments, it will be understood by those of ordinary skill in the art that：It still may be used
With technical scheme described in the above embodiments is modified or equivalent replacement of some of the technical features；
And these modifications or replacements, various embodiments of the present invention technical solution that it does not separate the essence of the corresponding technical solution spirit and
Range.
Claims (2)
1. a kind of Chinese medicine preparation preparation method for treating fatty liver and hyperlipidemia, which is characterized in that include the following steps：
(1) curcuma zedoary of certain mass, radix paeoniae rubra, hawthorn, gynostemma pentaphylla, Cassia occidentalis, giant knotweed, turmeric, Radix Astragali, matrimony vine are weighed；
(2) it takes the water of 6-8 times of weight of the total weight of the nine traditional Chinese medicines of the above selection to be decocted, decocts three times, boil every time
40-50 minutes, decoction liquor is filtered and merged, is concentrated into the inspissated juice of relative density 1.15-1.30 at a temperature of 80 DEG C, then
The ethyl alcohol that mass percent concentration is 95% is added under room temperature, it is stirring while adding, then place 24 hours or more, in extraction
Clear liquid；
(3) ethyl alcohol in supernatant is recycled, then gives back in the supernatant for harvest ethyl alcohol and sweetener is added, adjusts the PH of solution
Value is 5.0-7.0, finally adds suitable quantity of water；
(4) preparation can be completed in filtering, sterilizing and filling；Wherein：The mass parts of each traditional Chinese medicinal components are in step 1:15 parts of curcuma zedoary-
75 parts, 12 parts -60 parts of radix paeoniae rubra, 12 parts -60 parts of hawthorn, 12 parts -60 parts of gynostemma pentaphylla, 12 parts -60 parts of Cassia occidentalis, giant knotweed 15
- 75 parts of part, 12 parts -60 parts of turmeric, 15 parts -75 parts of Radix Astragali, 15 parts -75 parts of matrimony vine.
2. the Chinese medicine preparation preparation method according to claim 1 for treating fatty liver and hyperlipidemia, feature exists
In the addition for the ethyl alcohol that the mass percent concentration is 95% is 1.2-2 times of the gross mass of inspissated juice.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410794632.XA CN104524448B (en) | 2014-12-18 | A kind of Chinese medicine preparation preparation method for treating fatty liver and hyperlipidemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410794632.XA CN104524448B (en) | 2014-12-18 | A kind of Chinese medicine preparation preparation method for treating fatty liver and hyperlipidemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104524448A CN104524448A (en) | 2015-04-22 |
| CN104524448B true CN104524448B (en) | 2018-08-31 |
Family
ID=
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101244157A (en) * | 2007-02-15 | 2008-08-20 | 南京万舜源生物科技有限公司 | Natural plants extract, preparation method and application thereof |
| CN102423413A (en) * | 2012-01-04 | 2012-04-25 | 陈伯明 | Medicament for treating hyperlipemia and fatty liver and preventing atherosclerosis as well as applications thereof |
| CN103705854A (en) * | 2013-12-30 | 2014-04-09 | 郭兰春 | Semen cassiae, fructus lycii and glossy privet fruit oral solution with functions of tonifying liver and reducing fat |
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101244157A (en) * | 2007-02-15 | 2008-08-20 | 南京万舜源生物科技有限公司 | Natural plants extract, preparation method and application thereof |
| CN102423413A (en) * | 2012-01-04 | 2012-04-25 | 陈伯明 | Medicament for treating hyperlipemia and fatty liver and preventing atherosclerosis as well as applications thereof |
| CN103705854A (en) * | 2013-12-30 | 2014-04-09 | 郭兰春 | Semen cassiae, fructus lycii and glossy privet fruit oral solution with functions of tonifying liver and reducing fat |
Non-Patent Citations (1)
| Title |
|---|
| 140味降脂中药治疗高脂血症的用药规律分析;钟周等;《湖南中医药大学学报》;20150131;第35卷(第1期);第64-66页 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100443112C (en) | Medicine for treating gout and gout arthritis | |
| CN108524673A (en) | A kind of Chinese medicine composition and its application | |
| CN101485834B (en) | Chinese medicine for treating diabetes | |
| CN102048821A (en) | Method for preparing perhexiline pharmaceutical preparation | |
| CN1814162A (en) | Pulse-promoting large-volume injecta and preparing method | |
| CN103751450B (en) | A kind of composition for treating diabetic nephropathy | |
| CN104524448B (en) | A kind of Chinese medicine preparation preparation method for treating fatty liver and hyperlipidemia | |
| CN1718193A (en) | Total secondary ginseng glucoside medicine composition, its prepn. method and application in preparing medicine for treating myocardial ischemia and hemorrhagic shock | |
| CN104491725B (en) | A kind of Chinese medicine preparation for treating fatty liver and hyperlipidemia | |
| CN104547261A (en) | Medicine for treating hyperlipidemia | |
| CN106620253B (en) | Traditional Chinese medicine composition for treating bradyarrhythmia | |
| CN105147944B (en) | A kind of Chinese medicine composition, its preparation and its preparation method and application | |
| CN1718191A (en) | Total secondary ginseng glucoside oral disintegration tablets prepn. method and application thereof | |
| CN104189314B (en) | It is a kind of to treat the turbid pharmaceutical composition for checking card high fat of blood of phlegm | |
| CN104524448A (en) | Preparation method of traditional Chinese medicine preparation for treating fatty liver and hyperlipidaemia | |
| CN103623103B (en) | Traditional Chinese medicine preparation for treating coughing and phlegmy throat | |
| CN102114185A (en) | Medicament for treating insulin resistance of type 2 diabetes | |
| CN106728828A (en) | A kind of Chinese medicine preparation and its preparation technology for treating coronary heart disease | |
| CN107137621A (en) | It is a kind of to treat Chinese medicine composition of high fat of blood and its preparation method and application | |
| JPS5813518A (en) | Preparation of drug consisting of ganoderma lucidum and elfvingia applanata | |
| CN105920288B (en) | Improve Chinese medicine preparation of insulin resistance syndrome and preparation method and application | |
| CN106262818A (en) | A kind of blood sugar lowering oral liquid and preparation method thereof | |
| CN103893327A (en) | Traditional Chinese medicine preparation for treating hyperlipidaemia and preparation method thereof | |
| CN104623214B (en) | A kind of Chinese medicine composition and preparation method thereof | |
| CN112426459A (en) | Pure traditional Chinese medicine transdermal liniment for treating diabetes and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Geng Xiuli Inventor after: Zhang Zhengchen Inventor after: Ma Junjie Inventor after: Wang Huamin Inventor after: Lv Hongdi Inventor after: Wang Xidong Inventor after: Hao Shaojun Inventor after: Sun Jianhua Inventor after: Li Xianyu Inventor after: Li Wenjun Inventor before: Geng Xiuli Inventor before: Lv Hongdi Inventor before: Wang Xidong Inventor before: Hao Shaojun Inventor before: Sun Jianhua Inventor before: Li Xianyu Inventor before: Li Wenjun Inventor before: Zhang Zhengchen |
|
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180831 Termination date: 20201218 |